Premium
Plant‐made pharmaceuticals: Leading products and production platforms
Author(s) -
Paul Matthew,
Ma Julian KC.
Publication year - 2011
Publication title -
biotechnology and applied biochemistry
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.468
H-Index - 70
eISSN - 1470-8744
pISSN - 0885-4513
DOI - 10.1002/bab.6
Subject(s) - production (economics) , microbiology and biotechnology , product (mathematics) , biochemical engineering , pharmaceutical industry , business , risk analysis (engineering) , engineering , biology , economics , geometry , mathematics , macroeconomics
The number of approaches to recombinant protein production in plants is greater than ever before. Development of these new and improved technologies as production platforms for plant‐made pharmaceuticals has and will continue to create new commercial opportunities in the pharmaceutical sector. However, it is inevitable that no single system will be optimal for the production of all recombinant proteins of interest in plants due to both the physical characteristics and the envisaged therapeutic application of each product. Here, we review a range of promising product/platform pairs emphasizing synergies during production and in clinical trials.